Vivinavi

REGISTER: Obesity Treatment Seminar

----------------------------------------------------------------------------
To view this message in HTML format, click here:
(/rest/head/mirrorPage/@9YkDjcpG3odtGj_ykLtDTaDDRqx6_lU5z9wSbW4OmqosWdf3acy5WR6JDi-vpWw76rpSoEZ2c8ACyXlMlkO0nX0_QbK4FVSDvA_IKImDc63U0yJp.html)
or copy and paste this link into your web browser
----------------------------------------------------------------------------
















Please join CDC’s Division of Nutrition, Physical Activity, and Obesity (DNPAO) for






Advances in Evidence-based Obesity Treatment: New Anti-Obesity Medications as Companions to Behavior and Lifestyle Programs






 Thursday,  October 24, 2024
2—3 p.m. ET





The DNPAO Seminar Series showcases the latest research, guidelines, and successes. The Seminar Series is for partners, public health practitioners, and other professionals interested in nutrition, physical activity, and obesity.The October 24 seminar will provide invaluable insight into advances in evidence-based obesity treatment. Hear about the metabolic disease of obesity and how the new FDA-approved anti-obesity medications work.Discover why nutrition and physical activity counseling along with behavior modification are still the cornerstone of obesity, diabetes, and cardiovascular disease prevention and treatment.Learn about the continued need for obesity and chronic disease prevention efforts at the policy, system, and community levels. Ask questions of experts in the field. 








Hints and reminders:Registration is required to get event login details.Add the event to your calendar.Share the registration link widely with those who may be interested.Use the link provided from your confirmation email to join the seminar.Please forward this invitation to anyone who may be interested in this seminar.If you have any questions, please email dnpaopolicy@cdc.gov.
Centers for Disease Control and Prevention
1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348Questions or Problems  |  Unsubscribe